AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+2.88%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$4.3B
AUM Growth
+$582M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
30.73%
Holding
273
New
80
Increased
94
Reduced
45
Closed
48
Top Buys
| 1 |
UnitedHealth
UNH
|
$71.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$70M |
| 3 |
Colgate-Palmolive
CL
|
$63.5M |
| 4 |
Johnson & Johnson
JNJ
|
$61.7M |
| 5 |
Dentsply Sirona
XRAY
|
$55.8M |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
$73.1M |
| 2 |
Freshpet
FRPT
|
$62.8M |
| 3 |
PARA
Paramount Global Class B
PARA
|
$49.9M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$47.7M |
| 5 |
AB InBev
BUD
|
$29.9M |
Sector Composition
| 1 | Healthcare | 70.36% |
| 2 | Consumer Staples | 8.49% |
| 3 | Consumer Discretionary | 7.88% |
| 4 | Technology | 7.45% |
| 5 | Communication Services | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
26
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $55.5M | 0.8% |
256,000
+204,000
| +392% | +$44.2M |
|
27
Medtronic
MDT
$120B
| $54.7M | 0.79% |
678,000
+6,000
| +0.9% | +$484K |
|
28
Central Garden & Pet Class A
CENTA
$2.11B
| $53.3M | 0.77% |
1,705,000
-181,250
| -10% | -$5.67M |
|
29
Intuitive Surgical
ISRG
$162B
| $53.1M | 0.77% |
208,000
+8,000
| +4% | +$2.04M |
|
30
Novo Nordisk
NVO
$250B
| $46.5M | 0.67% |
584,000
-40,000
| -6% | -$3.18M |
|
|
PARA
31
DELISTED
Paramount Global Class B
PARA
| $46M | 0.66% |
2,064,000
-2,236,000
| -52% | -$49.9M |
|
32
Aurinia Pharmaceuticals
AUPH
$1.63B
| $45.7M | 0.66% |
4,172,000
-828,000
| -17% | -$9.07M |
|
33
Post Holdings
POST
$5.92B
| $45.7M | 0.66% |
508,410
+191,410
| +60% | +$17.2M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $44.7M | 0.64% |
1,836,000
+44,000
| +2% | +$1.07M |
|
35
FibroGen
FGEN
$47.2M
| $43.1M | 0.62% |
92,480
-62,080
| -40% | -$29M |
|
36
MacroGenics
MGNX
$123M
| $42.7M | 0.62% |
5,960,000
-132,000
| -2% | -$946K |
|
|
37
Regeneron Pharmaceuticals
REGN
$59.8B
| $42.7M | 0.62% |
52,000
-58,000
| -53% | -$47.7M |
|
38
Biohaven
BHVN
$1.68B
| $42.7M | 0.61% |
3,124,000
+400,000
| +15% | +$5.46M |
|
|
DICE
39
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $39.4M | 0.57% |
+1,376,000
| New | +$39.4M |
|
40
CRISPR Therapeutics
CRSP
$4.73B
| $37.3M | 0.54% |
824,000
-212,000
| -20% | -$9.59M |
|
41
Uber
UBER
$193B
| $34.6M | 0.5% |
1,092,000
+468,000
| +75% | +$14.8M |
|
42
Kraft Heinz
KHC
$31.8B
| $32.9M | 0.47% |
850,000
+160,000
| +23% | +$6.19M |
|
43
Toast
TOST
$24.3B
| $32.3M | 0.47% |
1,820,370
+564,370
| +45% | +$10M |
|
44
Orthofix Medical
OFIX
$585M
| $30.8M | 0.44% |
1,836,000
+1,036,000
| +130% | +$17.4M |
|
45
DocuSign
DOCU
$15.4B
| $30.5M | 0.44% |
524,000
+108,000
| +26% | +$6.3M |
|
|
EVBG
46
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $29.5M | 0.42% |
850,000
-222,000
| -21% | -$7.7M |
|
47
CareDx
CDNA
$688M
| $28.7M | 0.41% |
3,136,000
+2,636,000
| +527% | +$24.1M |
|
48
Voyager Therapeutics
VYGR
$207M
| $27.2M | 0.39% |
3,524,000
+128,000
| +4% | +$987K |
|
49
Thermo Fisher Scientific
TMO
$183B
| $24.2M | 0.35% |
42,000
+14,000
| +50% | +$8.07M |
|
50
Yum! Brands
YUM
$39.7B
| $23.9M | 0.34% |
181,000
+26,000
| +17% | +$3.43M |
|